J. Arnold Wealth Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

J. Arnold Wealth Management’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-155	Closed	-$11.8K	–	40
2023 Q1	$11.8K	Buy	155 +1	+0.6%	+$77	0.01%	50
2022 Q4	$12.1K	Buy	+154	New	+$11.8K	0.01%	70
2021 Q4	–	Sell	-1,683	Closed	-$130K	–	66
2021 Q3	$130K	Buy	1,683 +3	+0.2%	+$242	0.06%	44
2021 Q2	$135K	Buy	1,680 +1,528	+1,005%	+$121K	0.07%	51
2021 Q1	$12K	Buy	+152	New	+$11.9K	0.01%	81
2020 Q1	–	Sell	-5,402	Closed	-$350K	–	63
2019 Q4	$350K	Buy	+5,402	New	+$329K	0.45%	33

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

PWW

Pettyjohn Wood & White Lynchburg, Virginia $687M AUM 24.61% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

J. Arnold Wealth Management's PJP Position: Q2 2023 in Review

J. Arnold Wealth Management sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2023, closing a stake of 155 shares — an estimated $11.8K sold.

J. Arnold Wealth Management first reported a position in PJP in Q4 2019 and held it in 6 quarters. The position peaked at $350K in Q4 2019. 87 funds tracked by Wall St. Rank hold PJP as of Q2 2023.

J. Arnold Wealth Management reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2023 after selling out during the quarter.
J. Arnold Wealth Management sold 155 Invesco Pharmaceuticals ETF shares in Q2 2023, an estimated $11.8K.
J. Arnold Wealth Management first reported a position in Invesco Pharmaceuticals ETF in Q4 2019 and held it in 6 quarters.
J. Arnold Wealth Management's Invesco Pharmaceuticals ETF position peaked at $350K in Q4 2019.
87 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2023.

Based on J. Arnold Wealth Management's 13F filing for Q2 2023, filed 9 Aug 2023.